Cti Biopharma Corp buy Needham & Company LLC
Start price
20.04.23
/
50%
€4.61
Target price
20.04.24
€8.20
Performance (%)
81.37%
End price
21.04.24
-
Summary
This prediction is currently being closed. With a performance of 81.37% the BUY prediction by Needham___Company_LL is a big success. Needham___Company_LL has 50% into this predictionPerformance without dividends (%)
| Name | 1w | 1m | 1y |
|---|---|---|---|
| Cti Biopharma Corp | - | - | - |
| iShares Core DAX® | -1.212% | 1.925% | 17.589% |
| iShares Nasdaq 100 | -4.714% | -1.810% | 0.450% |
| iShares Nikkei 225® | -2.976% | -2.660% | 10.156% |
| iShares S&P 500 | -2.744% | -0.448% | 0.320% |
Comments by Needham___Company_LL for this prediction
In the thread Cti Biopharma Corp diskutieren
CTI BioPharma Corp. (NASDAQ: CTIC) had its "buy" rating re-affirmed by analysts at Needham & Company LLC. They now have a $9.00 price target on the stock.
Ratings data for CTIC provided by MarketBeat
In the thread Trading Cti Biopharma Corp
Die von Needham___Company_LL gewählte maximale Laufzeit wurde überschritten